CLINICAL TRIALS PROFILE FOR PEFICITINIB
✉ Email this page to a colleague
Clinical Trials for Peficitinib
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT01096862 ↗ | A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis | Completed | Astellas Pharma Inc | Phase 2 | The purpose of this study is to explore the efficacy and safety of multiple, escalating doses of ASP015K when compared to placebo in subjects with moderate to severe plaque psoriasis. |
NCT01225224 ↗ | Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers | Completed | Astellas Pharma Inc | Phase 1 | A study to evaluate the safety, tolerability and PK profiles of single and multiple doses of ASP015K in healthy nonelderly men. |
NCT01554696 ↗ | A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate | Completed | Astellas Pharma Inc | Phase 2 | The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis subjects who are methotrexate-inadequate responders (MTX-IR). |
NCT01565655 ↗ | A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis | Completed | Astellas Pharma Global Development, Inc. | Phase 2 | The purpose of this study is to evaluate the safety and efficacy of ASP015K in moderate to severe rheumatoid arthritis (RA) subjects |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Peficitinib
Condition Name
Clinical Trial Locations for Peficitinib
Trials by Country
Clinical Trial Progress for Peficitinib
Clinical Trial Phase
Clinical Trial Sponsors for Peficitinib
Sponsor Name